Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

708
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
708
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

816
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
816
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

757
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
757
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

802
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
802
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

445
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
445

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Real-world safety profile of mosunetuzumab: a pharmacovigilance study based on the food and drug administration adverse event reporting system.

Frontiers in pharmacology·2026
Same author

Surface Microstructural Reconstruction of CdS Buffers Enables Low-Voltage-Loss Kesterite Solar Cells With >15% Efficiency.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

CEDR: robust consensus cancer subtyping with multi-omics data via ensemble dimensionality reduction.

Briefings in bioinformatics·2026
Same author

PhysicsHap: A Modular Haptic Interaction Framework for Enhancing Student Learning in Immersive Virtual Physics Experiments.

IEEE transactions on visualization and computer graphics·2026
Same author

Hyaluronic acid-based control/target delivery system: Formation, control release and applications.

Food chemistry·2026
Same author

Psychotic-like experiences as precursors to emotional symptoms in adolescents: a longitudinal network analysis.

Child and adolescent psychiatry and mental health·2026

相关实验视频

Updated: Mar 30, 2026

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
13:41

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

3.0K

初级心脏内皮肉瘤:一个病例报告

Shishi Zhong1, Yanhong Luo1, Yunxia Fei1

  • 1Affiliated Hospital of Hangzhou Normal University, Hangzhou City, China.

Journal of medical case reports
|September 27, 2025
PubMed
概括
此摘要是机器生成的。

初级心脏内肉瘤是一种罕见的癌症,预后不佳. 包括手术,化疗和向anlotinib在内的多式疗法在MDM2放大患者中实现了超过1年的存活率,提供了新的治疗见解.

关键词:
心脏肉瘤是什么心脏肉瘤是什么心脏肉瘤心脏超声波扫描是指心脏的超声波扫描.病理学 病理学 病理学手术切除的瘤的切除.系统化疗是一种全身化疗.

更多相关视频

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients
09:16

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients

Published on: February 28, 2018

8.1K
Intramyocardial Cell Delivery: Observations in Murine Hearts
08:12

Intramyocardial Cell Delivery: Observations in Murine Hearts

Published on: January 24, 2014

14.2K

相关实验视频

Last Updated: Mar 30, 2026

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
13:41

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

3.0K
Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients
09:16

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients

Published on: February 28, 2018

8.1K
Intramyocardial Cell Delivery: Observations in Murine Hearts
08:12

Intramyocardial Cell Delivery: Observations in Murine Hearts

Published on: January 24, 2014

14.2K

科学领域:

  • 心血管瘤学心血管瘤学
  • 罕见的癌症 罕见的癌症
  • 基因组医学是基因组医学.

背景情况:

  • 初级心脏内肉瘤是一种异常罕见且具有攻击性的恶性瘤,平均存活率低于1年.
  • MDM2放大是一种罕见的基因变异,在一些心脏瘤中发现.
  • 治疗选择有限,导致这种疾病的预后不佳.

研究的目的:

  • 报告一种罕见的初级心脏内脏肉瘤与MDM2放大.
  • 描述多模式治疗方法及其对患者生存的影响.
  • 为了解决这种高度致命的疾病提供了洞察力.

主要方法:

  • 一名48岁的妇女出现了大左心房质量的症状.
  • 通过组织病理学和遗传分析证实了MDM2扩增的内肉瘤的诊断.
  • 治疗涉及手术切除,随后进行连续治疗,包括脂质体 doxorubicin,anlotinib 和组合化疗.

主要成果:

  • 患者成功地进行了心脏瘤的手术切除.
  • 尽管最初的复发,连续治疗导致部分瘤回归和临床稳定.
  • 患者在持续治疗的情况下,在诊断后超过1年的生存时间.

结论:

  • 结合手术,化疗和向治疗可能会延长原发性心脏内肉瘤的存活时间.
  • 基于anlotinib的治疗显示出管理MDM2-放大心脏内肉瘤的潜力.
  • 这一案例强调了对新型治疗策略进行进一步临床研究的必要性.